• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Study finds tactile Ring-IT adaptor effective for visually impaired eye drop users

News
Article

The adaptor was tested by low-vision patients and participants with simulated visual impairment.

(Image Credit: AdobeStock/New Africa)

(Image Credit: AdobeStock/New Africa)

A novel tactile 3-dimensional bottle ring adaptor, Ring-IT, developed to improve the identification and dosing frequency of eye drops for low-vision patients, was found to be efficacious in this patient population,1 according to first author Praveena K Gupta, PhD. She is associate professor, Department of Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston.

This new device addresses a challenge commonly faced by low-vision patients, namely, adhering to dosing frequency when managing multiple eye drop medication bottles.

In a study to test how well the ring adaptor worked, Gupta and colleagues conducted a 2-phase study, first in healthy subjects and then then in visually impaired patients. The adaptors designed to be placed on the medication bottlenecks had either 1, 2, or 3 protrusions with cube or sphere endings.

Ring-IT was designed using a 3D printed model of a rigid plastic ring clip, and manufactured at Maker Health Space Medical Fabrication Laboratory at the University of Texas Medical Branch at Galveston.

In phase 1, 20 healthy subjects experienced 20/200 low vision in a vision simulator. In phase 2, 26 visually impaired patients with 20/70 or worse vision were randomized to 6 combinations of varying protrusions and shapes on the bottlenecks and they were tasked with identifying the shapes and protrusion during different presentations. The patients’ responses and time to identify the bottleneck characteristics were recorded.

The investigators reported that in phase 1, 98.3% of subjects correctly identified the number of protrusions, the mean time to which was 4.5±6.1 seconds. The cubes and spheres were identified correctly, respectively, 91.7% and 73.3% of the time (average identification times, 9.9±7.6 and 10.9±9.0 seconds).

In phase 2, 92.3% of subjects correctly identified the number of protrusions (mean identification time, 6.0±3.0 seconds. The patients’ success rates with identifying the cubes and spheres were 78.2% and 74.4%, respectively average identification time, 7.5±4.8 and 8.5±5.6 seconds, respectively.

The researchers concluded, “Ring-IT was identified with accuracy and speed by both low-vision simulated subjects, and by patients with true limited visual capabilities. These tactile bottleneck ring adaptors can be used as an assistive low-vision aid device and may increase eye drop regimen adherence in visually impaired patients.”

The researchers believe that their study “holds breakthrough potential to catalyze a shift in clinical practice, providing a practical tool to enhance topical eye drop adherence in patients with visual impairment. This innovation could have a profound impact on both patient care and policy considerations,” they said.

Reference:
  1. Gupta PK, Ishihara R, Zhao Z, et al. Novel tactile bottle neck adaptor facilitates eye drop adherence in visually impaired patients. BMJ Open Ophthalmol. 2023;8:e001462. doi:10.1136/bmjophth-2023-001462
Related Videos
Alice Epitropoulos, MD, and Laura M. Periman, MD
This series features 1 KOL.
Alice Epitropoulos, MD, and Laura M. Periman, MD
This series features 1 KOL.
Video 2 - 1 KOL is featured in, "Advances in Technology for SMILE procedure"
Video 1 - 1 KOL is featured in, "Overview of Small Incision Lenticule Extraction (SMILE)"
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
© 2024 MJH Life Sciences

All rights reserved.